Disease-modifying drugs for multiple sclerosis must be globally available according to therapeutic guidelines suitable to different regions of the world
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Academia Brasileira de Neurologia (ABNEURO)
2012-10-01
|
Series: | Arquivos de Neuro-Psiquiatria |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2012001000001&lng=en&tlng=en |